Prediction of early mortality with non-intensive acute myeloid leukemia (AML) Therapies: analysis of 1336 patients from MRC/NCRI and SWOG
Authors
Wang, X.Thomas, I.
Ariti, C.
Dennis, Michael
Mehta, P.
Russel, N. H.
Sydenham, M.
Hills, R.
Burnet, A. K.
Nand, S.
Assouline, S.
Michaelis, L. C.
Erba, H. P.
Kerr, K.
Walter, R. B.
Othus, M.
Affiliation
University of Washington, Seattle, WAIssue Date
2021
Metadata
Show full item recordCitation
Wang X, Thomas I, Ariti C, Dennis M, Mehta P, Russel NH, et al. Prediction of Early Mortality with Non-Intensive Acute Myeloid Leukemia (AML) Therapies: Analysis of 1336 Patients from MRC/NCRI and SWOG. Blood. 2021 Nov;138. PubMed PMID: WOS:000736398800218.Journal
BloodDOI
10.1182/blood-2021-151597Additional Links
https://dx.doi.org/10.1182/blood-2021-151597Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2021-151597